1. Home
  2. LICN vs ANIX Comparison

LICN vs ANIX Comparison

Compare LICN & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

HOLD

Current Price

$3.16

Market Cap

53.1M

Sector

N/A

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.21

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
ANIX
Founded
2004
1982
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
135.3M
IPO Year
2023
1987

Fundamental Metrics

Financial Performance
Metric
LICN
ANIX
Price
$3.16
$3.21
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.00
AVG Volume (30 Days)
63.2K
424.5K
Earning Date
12-19-2025
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,641,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$2.07
52 Week High
$56.42
$5.46

Technical Indicators

Market Signals
Indicator
LICN
ANIX
Relative Strength Index (RSI) 46.51 35.43
Support Level $3.01 $4.20
Resistance Level $3.74 $3.64
Average True Range (ATR) 0.48 0.44
MACD 0.04 -0.20
Stochastic Oscillator 15.10 1.33

Price Performance

Historical Comparison
LICN
ANIX

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: